SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

State-owned LIC has cut its stake in Ranbaxy Laboratories by selling more than 2% stake over the past five years. The country’s largest insurer offloaded 45,08,036 shares of Ranbaxy between October 15, 2008 and December 20, 2013 through open markets.

Following the stake sale, LIC’s stake in the company has come down to 6.13% from 8.15%.

During the period from October 15, 2008 and December 20, 2013, Ranbaxy was taken over by Japan’s Daiichi Sankyo. The company was also in various regulatory troubles during this period.

Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×